PHASE II Clinical Trial Randomized And Controlled To Assess Need Of Oxygen On Day 14 After Administration Of Passive Immunotherapy In Patients Infected By SARS-CoV-2 With Risks Factors For Severe Disease

Fundacin Biomedica Galicia Sur, NCT05578391, CoV-PlasGal, NCT05578391, Mar 2021
61 patient convalescent plasma late treatment RCT with results not reported over 5 years after completion.
29 convalescent plasma RCTs have results missing long after expected1-29
The trials report a total of 3,534 patients, with 15 trials having actual enrollment of 1,143, and the remainder estimated.
Fundacin Biomedica Galicia Sur et al., 31 Mar 2021, Randomized Controlled Trial, Spain, trial NCT05578391 (history) (CoV-PlasGal).
Late treatment
is less effective